The development of chiral hydrogen donor catalysts is
fundamental
in the expansion and innovation of asymmetric organocatalyzed reactions
via an enantioselective hydrogen atom transfer (HAT) process. Herein,
an unprecedented type of chiral C2-symmetric arylthiol
catalysts derived from readily available enantiomeric lactate ester
was developed. With these catalysts, an asymmetric anti-Markovnikov
alkene hydroamination–cyclization reaction was established,
affording a variety of pharmaceutically interesting 3-substituted
piperidines with moderate to high enantioselectivity. Results of the
designed control experiments and theoretical computation rationalized
the origin of stereocontrol and disclosed the spatial effect of the
moiety of chiral thiols on the enantioselectivity. We believed the
facile synthesis, flexible tunability, and effective enantioselectivity-controlling
capability of these catalysts would shed light on the development
of versatile chiral HAT catalysts and related asymmetric reactions.